✦ LIBER ✦

An open phase II trial of gemcitabine, oxaliplatin and vinorelbine combination as first-line therapy in advanced non-small cell lung cancer patients

✍ Scribed by Trédaniel, J.; Becht, C.; Bekradda, M.; De Cremoux, H.; Alexandre, J.; Chomy, F.; Szyldergemajn, S.; Yataghene, Y.; Culine, S.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine and vinorelbine as first-lin

✍ E Laack; T Mende; J Benk; A Chemaissani; J Scholtze; C Lorenz; A Niestroy; K Dal 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Gemcitabine and vinorelbine in advanced

✍ Vázquez, F; Barón, FJ; Cueva, JF; Candamio, S; Calvo, M; Irigoyen, A; Huidobro, 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Gemcitabine, vinorelbine and cisplatin c

✍ E Laack; T Mende; H Dürk; M Kneba; N Dickgreber; T Welte; T Müller; J Scholtze; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Phase II study of gemcitabine plus oxali

✍ Cappuzzo, F; Novello, S; De Marinis, F; Franciosi, V; Maur, M; Ceribelli, A; Lor 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 117 KB

Phase II trial of weekly docetaxel and g

✍ Sujith Kalmadi; Giles McNeill; Mellar Davis; David Peereboom; David Adelstein; T 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 68 KB

Phase II trial of vinorelbine (VNR) and

✍ Garcia-Gomez, J; Firvida, J; Garcia-Mata, J; Salgado, M; Calvo, M; Rodriguez, R 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 227 KB